Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Small Molecule Drug Discovery Market?

Over the last few years, the market for small molecule drug discovery has significantly expanded. Its size is predicted to increase from $62.44 billion in 2024 to $67.94 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this historical growth include initiatives for drug repurposing, introduction of automation in drug discovery, more investment in research and development, regulatory backing for drug development, and progress in high-throughput screening processes.

The market size for small molecule drug discovery is predicted to witness a remarkable surge in the coming years. The expectation is that it will expand to “$104.6 billion in 2029, reflecting a compound annual growth rate (CAGR) of 11.4%.” This expected increase during the forecast period can be linked to factors such as the introduction of new therapeutic targets, drug discovery focused on the patient, combination products of drugs and devices, the implementation of real-world evidence, integration of pharmacogenomics, and global health challenges. Key trends for the forecast period encompass fragment-based drug discovery, the incorporation of artificial intelligence into drug discovery, therapeutics targeting RNA, collaborations and partnerships, drug delivery innovations, and the use of organoids and 3D cell culture models.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

Which Factor Is Shaping The Future Of The Small Molecule Drug Discovery Market?

The small molecule drug discovery market’s growth is anticipated to be propelled by the increasing prevalence of chronic diseases. Chronic diseases are long-term conditions that typically require consistent medical attention and can significantly interfere with everyday activities. Small-molecule drugs are often used to manage chronic illnesses such as HIV, cancer, infections, heart disease, and kidney disease. These drugs are usually more cost-effective for individuals with chronic ailments. Therefore, the escalating prevalence of these conditions is projected to stimulate the small molecule drug discovery market’s growth. A study conducted by the National Institutes of Health (NIH), an American biomedical research institution, predicts a 99.5% surge in the number of people aged 50 and above in the U.S suffering from at least one chronic disease, increasing from 71.522 million in 2020 to 142.66 million by 2050. Simultaneously, the number of people affected by multiple chronic conditions is expected to increase by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Thus, the growing prevalence of chronic diseases is fueling the expansion of the small molecule drug discovery market.

What Is The Segment-Wise Breakdown Of The Small Molecule Drug Discovery Market?

The small molecule drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule Drugs, Biologic Drugs

2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others

3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others

4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization

5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Subsegments:

1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs

2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

Which Trends Are Redefining The Future Landscape Of The Small Molecule Drug Discovery Industry?

The driving trend gaining traction in the small molecule drug discovery market is technological advancements. Prominent companies in this market are prioritizing the development of fresh products. To illustrate, Dotmatics, an American company providing digital science platforms, introduced their Small Molecule Drug Discovery Solution in January 2023. This distinctive solution is equipped with an integrated scientific R&D platform consisting of predefined workflows and enhanced data management capabilities. It diminishes operative inefficiencies while accelerating the progression from insights to decisions.

Which Companies Hold The Largest Market Share In The Small Molecule Drug Discovery Sector?

Major companies operating in the small molecule drug discovery market include Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Clinuvel Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Pharmacosmos, Allarity Therapeutics, Xellia Pharmaceuticals, Cyteir Therapeutics, BigHat Biosciences

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

How Does Regional Performance Compare Across The Small Molecule Drug Discovery Industry?

North America was the largest region in the small molecule drug discovery market in 2024. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9834&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model